Growth is fueled by the rising number of temperature-sensitive pharmaceuticals, including biologics, vaccines, and specialty ...

It takes an average of 22 months for a new drug to be listed on the Pharmaceutical Benefits Scheme after it's been deemed safe and effective, according to a recent review.

Dividend stocks are returning in favor as bond yields plunge, and these five Dividend Kings are all buy-rated on Wall Street.

In preparation for a planned commercial rollout, Telix has contracted with Cardinal health to enable Zircaix®2 availability across a wide range of U.S. locations.